Covid-19 vaccines and atrial fibrillation

Graham Crawley made this Freedom of Information request to Medicines and Healthcare Products Regulatory Agency

Automatic anti-spam measures are in place for this older request. Please let us know if a further response is expected or if you are having trouble responding.

Medicines and Healthcare Products Regulatory Agency did not have the information requested.

Dear Medicines and Healthcare Products Regulatory Agency,
The Covid-19 vaccines are Pfizer BNT162B2, Oxford/Astrazeneca ChAdOx1-S [recombinant], Moderna mRNA-1273 and Johnson & Johnson JNJ-78436735, hereinafter "the vaccines"
Regarding the vaccines and atrial fibrillation, for each of the vaccines please provide the following information:
1. How many atrial fibrillation events have been reported following vaccination?
2. For vaccination recipients with a history of atrial fibrillation and whose hearts were in normal rhythm at the time of inoculation, how many atrial fibrillation events and/or deaths have been reported following vaccination?
3. For vaccination recipients with a history of atrial fibrillation and whose hearts were arrhythmic at the time of inoculation, how many atrial fibrillation events and/or deaths have been reported following vaccination?
4. Does the MHRA advise that sufferers of persistent atrial fibrillation are safe to be vaccinated with one of the vaccines?

Yours faithfully,

Graham Crawley

MHRA Customer Services, Medicines and Healthcare Products Regulatory Agency

Thank you for your email.  This auto-response is to inform you that your
email has been received and will be reviewed by our Customer Service Team.
We will respond to you as soon as possible. 
 
Please note that we may not respond if your query: 
 
• contains offensive language
• has already been answered in a previous reply to you
• is illegible
• is selling or promoting a product
• is for information only 
 
Medicines and Healthcare products Regulatory Agency
10 South Colonnade, 
Canary Wharf, 
London 
E14 4PU
gov.uk/mhra
Stay connected 
 
For information on how the Agency uses your personal data and your data
protection rights, please see our three centres’ Privacy Notices: MHRA,
CPRD and NIBSC. 
 
The UK has left the EU, and the transition period ends on 31 December
2020. Ourguidance and information can be accessed here.

________________________________________ From: Graham Crawley
<[FOI #824464 email]> Sent: Friday, January 21,
2022 11:59:58 AM To: MHRA Customer Services Subject: Freedom of
Information request - Covid-19 vaccines and atrial fibrillation Dear
Medicines and Healthcare Products Regulatory Agency, The Covid-19 vaccines
are Pfizer BNT162B2, Oxford/Astrazeneca ChAdOx1-S [recombinant], Moderna
mRNA-1273 and Johnson & Johnson JNJ-78436735, hereinafter "the vaccines"
Regarding the vaccines and atrial fibrillation, for each of the vaccines
please provide the following information: 1. How many atrial fibrillation
events have been reported following vaccination? 2. For vaccination
recipients with a history of atrial fibrillation and whose hearts were in
normal rhythm at the time of inoculation, how many atrial fibrillation
events and/or deaths have been reported following vaccination? 3. For
vaccination recipients with a history of atrial fibrillation and whose
hearts were arrhythmic at the time of inoculation, how many atrial
fibrillation events and/or deaths have been reported following
vaccination? 4. Does the MHRA advise that sufferers of persistent atrial
fibrillation are safe to be vaccinated with one of the vaccines? Yours
faithfully, Graham Crawley
------------------------------------------------------------------- Please
use this email address for all replies to this request:
[FOI #824464 email] Is [MHRA request email] the wrong
address for Freedom of Information requests to Medicines and Healthcare
Products Regulatory Agency? If so, please contact us using this form:
https://eur01.safelinks.protection.outlo...
Disclaimer: This message and any reply that you make will be published on
the internet. Our privacy and copyright policies:
https://eur01.safelinks.protection.outlo...
For more detailed guidance on safely disclosing information, read the
latest advice from the ICO:
https://eur01.safelinks.protection.outlo...
Please note that in some cases publication of requests and responses will
be delayed. If you find this service useful as an FOI officer, please ask
your web manager to link to us from your organisation's FOI page.

show quoted sections

MHRA Customer Services, Medicines and Healthcare Products Regulatory Agency

Our Ref: FOI 22/396

Dear Graham Crawley,

RE: REQUEST UNDER THE FREEDOM OF INFORMATION ACT 2000

Thank you for your enquiry which we received on 21st January 2022.

I confirm that your request is now being handled under the Freedom of Information Act and you should receive a reply within 20 working days from our date of receipt.

If you need to contact us again about this request, please quote the reference number above.

Please be aware that we publish FOIs replies and these are redacted and are located on our website at the following link below.
https://www.gov.uk/government/collection...

Kind Regards,

MHRA Customer Experience Centre
Communications and engagement team
Medicines and Healthcare products Regulatory Agency
10 South Colonnade, Canary Wharf, London E14 4PU
Telephone 020 3080 6000

show quoted sections

Pharmacovigilanceservice, Medicines and Healthcare Products Regulatory Agency

1 Attachment

Dear Graham Crawley,

Please find attached a response to your FOI request.

Kind regards,

FOI Team
Vigilance and Risk Management of Medicines Division
Medicines and Healthcare Products Regulatory Agency
10 South Colonnade, Canary Wharf, London E14 4PU

show quoted sections